R162

Discontinued Product

6054 has been discontinued.

View all Other Dehydrogenases products.
说明: Glutamate dehydrogenase (GDH1) inhibitor
化学名: 1-Hydroxy-2-(2-propen-1-yl)-9,10-anthracenedione
纯度: ≥98% (HPLC)
说明书
引用文献
评论
文献 (2)

生物活性 for R162

R162 is a glutamate dehydrogenase (GHD1) inhibitor (IC50 = 23 μM). Decreases fumarate and ROS levels, attenuates glutathione peroxidase levels and inhibits cell proliferation in cancer cell lines. Attenuates viability of a range of cancer cell lines.

技术数据 for R162

分子量 264.28
公式 C17H12O3
储存 Store at -20°C
纯度 ≥98% (HPLC)
CAS Number 64302-87-0
PubChem ID 4412951
InChI Key IMUBGIOLZQTIGI-UHFFFAOYSA-N
Smiles OC1=C2C(C3=CC=CC=C3C(C2=CC=C1CC=C)=O)=O

上方提供的技术数据仅供参考。批次相关数据请参见分析证书。

Tocris products are intended for laboratory research use only, unless stated otherwise.

参考文献 for R162

参考文献是支持产品生物活性的出版物。

Jin et al (2015) Glutamate dehydrogenase 1 signals through antioxidant glutathione peroxidase 1 to regulate redox homeostasis and tumor growth. Cancer Cell. 27 257 PMID: 25670081

按标靶查看相关产品

按产品操作查看相关产品

查看全部 Other Dehydrogenase Inhibitors

关键词: R162, R162 supplier, glutamate, dehydrogenase, inhibitor, inhibits, GDH1, Other, Dehydrogenases, 6054, Tocris Bioscience

篇 R162 的引用文献

引用文献是使用了 Tocris 产品的出版物。

目前没有 R162 的引用文献。

R162 的评论

目前没有该产品的评论。 Be the first to review R162 and earn rewards!

Have you used R162?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

该领域的文献

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*请注意,Tocris 仅会向正规科研企业/机构地址发送文献。


Cancer Metabolism Research Product Guide

Cancer Metabolism Research Product Guide

This product guide reviews some of the main areas in cancer metabolism research and lists around 150 products that can be used to investigate metabolic pathways in cancer including:

Cancer Metabolism Poster

Cancer Metabolism Poster

This poster summarizes the main metabolic pathways in cancer cells and highlights potential targets for cancer therapeutics. Genetic changes and epigenetic modifications in cancer cells alter the regulation of cellular metabolic pathways providing potential cancer therapeutic targets.